DELIVER (Completed)
An International, Double-blind, Randomised Placebo-Controlled Phase III
Study to Evaluate the Effect of Dapagliflozin on Morbidity and Mortality in
Patients with HFpEF
- Medicine
- dapagliflozin
- Population
- Heart failure
- Phase
- III
- Starting year
- 2017
- More information
- Clinicaltrials.gov